- Agreement with HealthEngine to integrate its healthcare booking network into SleepCheck
- HealthEngine’s platform helps patients find and connect with healthcare service providers – it is Australia’s #1 go-to for healthcare bookings and has assisted 7m patients schedule over 30m appointments
- ResApp and HealthEngine to progress a revenue share model for each new patient referred through SleepCheck – unlocking a new revenue stream for the company
- Agreement provides excellent validation of ResApp’s offering from another industry-leading partner
Brisbane, Australia, 21 October 2020 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease is pleased to advise that it has signed a 12-month non-exclusive marketing agreement with Australia’s largest consumer healthcare network, HealthEngine (HealthEngine.com.au) to integrate its booking engine into ResApp’s mobile medical application, SleepCheck.
HealthEngine is a consent-driven platform that helps patients find, book and connect with healthcare service providers through its online booking network. The company assists patients in scheduling in-person and telehealth consults with healthcare providers across Australia. HealthEngine has Australia’s largest online patient network and has assisted over seven million Australians make more than 30 million bookings online.
Under the agreement, ResApp will integrate HealthEngine’s booking network into its SleepCheck application, in turn HealthEngine will also promote the use of SleepCheck. SleepCheck is ResApp’s easy to use, direct-to-consumer mobile application that uses accurate algorithms to assess a person’s risk of obstructive sleep apnoea (“OSA”) by analysing breathing and snoring sounds during sleep. It requires no accessories or hardware other than the user’s smartphone to make an assessment.
If SleepCheck identifies that a user is at risk of OSA, it directs them to see a doctor. By integrating HealthEngine’s booking engine directly into the application, it will allow users to easily and conveniently book an appointment with their GP or another healthcare professional through a dedicated landing page managed by HealthEngine.
ResApp retains the revenue derived from the app download and in addition will receive a share of the revenue from HealthEngine for every new patient referred through the SleepCheck application. While revenue from the agreement cannot be estimated at this early stage and is dependent on the number of new patients referred to HealthEngine through SleepCheck, ResApp remains confident of significant consumer uptake.
The revenue sharing model creates a new revenue stream for ResApp and provides the company with another partnership agreement to underpin scale up of the SleepCheck application. The agreement also provides additional validation of ResApp’s offering from a top-tier Australian digital healthcare company. The agreement has the potential to be extended by both parties.
CEO and Managing Director Dr Tony Keating said: “This partnership is a tremendous achievement for ResApp and highlights SleepCheck’s potential in the Australian market. The agreement with HealthEngine provides us with access to a trusted and reliable consumer healthcare network, which will further improve our offering by allowing users to immediately progress the treatment journey.
“This agreement is further evidence of ResApp’s ability to attract large, industry leading partners that it can leverage to drive growth well into the future. The company has a number of partnerships pending, which will provide it with a solid foundation to scale. I look forward to updating shareholders on these moving forward.”
About ResApp Health Limited
ResApp Health Limited (ASX: RAP) is a leading digital health company developing smartphone applications for the diagnosis and management of the respiratory disease. ResApp’s machine learning algorithms use sound to diagnose and measure the severity of respiratory conditions without the need for additional accessories or hardware. ResApp’s regulatory-approved and clinically validated products include ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department and primary care settings; and SleepCheck, a smartphone application which allows consumers to self-assess their risk of sleep apnoea. Both products are CE Marked in Europe and TGA approved in Australia. For more information, please visit www.resapphealth.com.au.
HealthEngine is Australia’s largest consumer healthcare network and the #1 go-to for healthcare bookings. Founded in 2006, by Dr. Marcus Tan, HealthEngine is on a mission to transform Australia’s healthcare by making it easier for people to connect with their healthcare providers online and for health practitioners to deliver a great patient experience through technology. More than 7 million Australians have made more than 30 million bookings on the platform. To find, book and manage medical and dental appointments, visit HealthEngine.com.au.
ResApp Health Limited
ABN 51 094 468 318
Level 12, 100 Creek St, Brisbane, QLD 4000
© 2020 ResApp Health Limited. All rights reserved. US Patent No. 10,098,569, Australian Patent No. 2013239327, Japanese Patent No. 6,435,257 and Patents Pending. ResApp Health®, the ResApp Health logo and ResAppDx® are registered trademarks of ResApp Health Limited in the United States and other countries. ResAppDx is not available for sale in the United States.